Infectious Disease Diagnostics Market

The global infectious disease diagnostics market is foreseen to grow by 6.2%, from USD 34.26 Billion in 2021 to USD 55.43 Billion in 2029. Rising technological advancements in infectious disease diagnostics, shift in focus from centralized laboratories to decentralized POC testing is to drive the market for the upcoming forecast period. However, unfavorable reimbursement scenario remains one factor hindering the market growth over the anticipated period.

Market Definition

What Is Infectious disease diagnostics?

A bacterium, virus, fungus, protozoan, or helminth is found in a patient with a clinical ailment that is compatible for the diagnosis of an infectious disease.

Market Overview

The infectious disease diagnostics market search study helps to thoroughly understand the current trend in the market competitive analysis of the players in the emerging market. Moreover, the DRO in the Infectious disease diagnostics market offers valuable perspicuity and a current scenario for making the right decision. The research study covers the eminent players in the market with a detailed analysis of the company and a financial overview containing their net sales, business mix and geographical reach It mainly focuses on the key developments of the products/services offered by the company in recent years. Besides, we at Zettabyte have the expertise to analyses the global infectious disease diagnostics market player's competitive landscape helping the client comprehend their specific strategic growth approaches.

Infectious disease diagnostics market study by "Zettabyte Analytics" offers details about the market scope, market segmentation, technological advancement in the infectious disease diagnostics market and highlights the optimistic, competitive landscape and trends enduring over the years.

Major players in the Infectious disease diagnostics market include Abbott Laboratories, Becton, Dickinson And Company, Biomérieux Sa, Bio-Rad Laboratories, Inc., Chembio Diagnostic Systems, Co-Diagnostics, Danaher Corporation, Diasorin S.P.A, Elitechgroup, Epitope Diagnostics, F. Hoffmann-La Roche Ltd., Genetic Signatures Ltd., Grifols S.A., Hologic, Inc., Inbios International, Meridian Bioscience, Meril Lifesciences Pvt. Ltd., Orasure Technologies, Ortho Clinical Diagnostics Holdings Plc, Perkinelmer, Inc., Qiagen N.V., Quidel Corporation, Seegene, Inc., Siemens Healthineers Ag, Sysmex Corporation, Thermo Fisher Scientific Inc., Trinity Biotech Plc, Trivitron Healthcare, Uniogen Oy, Vela Diagnostics.

COVID-19 Impact on Global Infectious Disease Diagnostics Market

The global impact of COVID-19 has lost millions of lives with a massive cost to the healthcare system. Moreover, the treatment cost for patients with COVID-19 has also had a financial impact globally. the impact of COVID-19 on the Infectious disease diagnostics market has forced the companies to change their sourcing, pricing, and promotion strategies. the infectious disease diagnostics market players are seen focusing more on optimizing the e-commerce networks with the rising innovations in the digital sector, which are creating new business models for the healthcare industry player.

Research Scope

The report provides market value for the base year 2021 and a yearly forecast from 2022 to 2029 in revenue (USD Million/ Billion). the market for each segment is present in North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the regional basis for the forecast mentioned above.

Key industry dynamics, regulatory scenarios, major material dynamics and infectious disease diagnostics market future markets are analyzed to understand their impact on demand for the forecast period. growth rates have been estimated using correlation, regression and time-series analysis.

Market Segmentation

For the purpose of this report, the global Infectious disease diagnostics market segmented on the basis of product type, type of testing, technology, disease type, end-use, and region:

Product Type Outlook:

On the basis of product type, the market is segmented into reagents, kits, and consumables, instruments, software & services.

Type of Testing Outlook:

On the basis of Type of Testing, the market is segmented into Laboratory Testing, POC Testing.

Technology Outlook:

On the basis of Technology, the market is segmented into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other technologies.

Figure 1 Infectious Disease Diagnostics Market By Technology (Market Size And Forecast By Value - USD Million, 2021 & 2029)

Disease Type Outlook:

On the basis of disease type, the market is segmented into covid-19, HIV, hospital-acquired infections, hepatitis, chlamydia trachomatis, Neisseria gonorrhea, HPV, tuberculosis influenza, syphilis.

End-use Outlook:

On the basis of end user, the market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, other end users.

Regional Outlook (Revenue, USD Million; 2021 & 2029)

Regional Outlook (Revenue, USD Million; 2018-2029)
North America	U.S.
	Canada
Europe	Germany
	U.K.
	France
	Spain
	Italy
	Rest of the Europe
Asia Pacific	India
	Japan
	China
	South Korea
	Australia
	Rest of Asia-Pacific
Middle East & Africa	UAE
	Saudi Arabia
	South Africa
	Rest of Middle East & Africa
Latin America	Brazil
	Mexico
	Argentina
	Rest of Latin America

Figure 2 Infectious Disease Diagnostics Market: Regional Dynamics

An exclusive infectious disease diagnostics market research report provides an in-depth analysis of the market dynamics across five regions: North America, Europe, South America, Asia-Pacific, Middle East, and Africa. Furthermore, the market has been evaluated by utilizing diverse research methodologies and internal statistical model.

Companies Considered And Profiled In This Market Study

The players operating in the market have undertaken several strategies related to the market in the period 2019-2021. some of the prominent players in the infectious disease diagnostics market include

·       Abbott Laboratories

·       Becton, Dickinson And Company

·       Biomérieux Sa

·       Bio-Rad Laboratories, Inc.

·       Chembio Diagnostic Systems

·       Co-Diagnostics

·       Danaher Corporation

·       Diasorin S.P.A

·       Elitechgroup

·       Epitope Diagnostics

·       F. Hoffmann-La Roche Ltd.

·       Genetic Signatures Ltd.

·       Grifols S.A.

·       Hologic, Inc.

·       Inbios International

·       Meridian Bioscience

·       Meril Lifesciences Pvt. Ltd.

·       Orasure Technologies

·       Ortho Clinical Diagnostics Holdings Plc

·       Perkinelmer, Inc.

·       Qiagen N.V.

·       Quidel Corporation

·       Seegene, Inc.

·       Siemens Healthineers Ag

·       Sysmex Corporation

·       Thermo Fisher Scientific Inc.

·       Trinity Biotech Plc

·       Trivitron Healthcare

·       Uniogen Oy

·       Vela Diagnostics

Global Infectious Disease Diagnostics Market Report Scope

Historical data	2018 - 2020
Base year for estimation	2021
Forecast period	2022 - 2029
Market size value in 2022	USD XX Billion
Revenue forecast in 2029	USD 55.43 Billion
Growth Rate	CAGR of 6.2% from 2022 to 2029
Quantitative units	Revenue in USD Million/Billion & CAGR from 2022 to 2029
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Product Type, Type of Testing, Technology, End-Use, Disease Type
Key companies profiled	Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc.
Regional Scope	North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Country Scope	U.S., Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia, South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina
Customization scope	Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

 

Product Type Outlook (Revenue, USD Million/Billion; 2018-2029)

·       Reagents, Kits, and Consumables

·       Instruments

·       Software & Services

Type of Testing Outlook (Revenue, USD Million/Billion; 2018-2029)

·       Laboratory Testing

·       POC Testing

Technology Outlook (Revenue, USD Million/Billion; 2018-2029)

·       Immunodiagnostics

·       Clinical Microbiology

·       PCR

·       INAAT

·       DNA Sequencing & NGS

·       DNA Microarray

·       Other technologies

Disease Type Outlook (Revenue, USD Million/Billion; 2018-2029)

·       COVID-19

·       HIV

·       Hospital-acquired Infections

·       Hepatitis

·       Chlamydia Trachomatis

·       Neisseria Gonorrhea

·       HPV

·       Tuberculosis

·       Influenza

·       Syphilis

·       Mosquito-borne Diseases

·       Other Infectious Diseases

End Use Outlook (Revenue, USD Million/Billion; 2018-2029)

·       Diagnostic Laboratories

·       Hospitals & Clinics

·       Academic Research Institutes

·       Other End Users

Regional Outlook (Revenue, USD Million/Billion; 2018-2029)

·       North America

o   U.S.

o   Canada

·       Europe

o   Germany

o   U.K.

o   France

o   Spain

o   Italy

o   Rest of the Europe

·       Asia Pacific

o   India

o   Japan

o   China

o   South Korea

o   Australia

o   Rest of Asia-Pacific

·       Middle East & Africa

o   UAE

o   Saudi Arabia

o   South Africa

o   Rest of Middle East & Africa

·       Latin America

o   Brazil

o   Mexico

o   Argentina

o   Rest of Latin America

Reasons to Buy the Report:

·       Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Infectious disease diagnostics market

·       Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.

·       The key findings and recommendations highlight crucial progressive industry trends in the Infectious disease diagnostics market, thereby allowing players to develop effective long-term strategies in order to garner their market revenue.

·       Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

·       Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.

·       Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.